8-K: Adtalem Global Education Reports Strong Q3 Fiscal Year 2025 Results, Raises Guidance

Adtalem Global Education announces a 12.9% year-over-year increase in revenue and raises its fiscal year 2025 guidance following a strong third quarter.

Summary

• Adtalem Global Education reported its third quarter fiscal year 2025 results, showing significant growth in enrollment and revenue.
• Total student enrollment reached 94,223, a 9.8% increase year-over-year.
• Revenue for the quarter was $466.1 million, up 12.9% compared to the previous year.
• Diluted earnings per share were $1.59, while adjusted EPS grew 28.0% year-over-year to $1.92.
• Adjusted EBITDA increased by 19.3% year-over-year to $127.8 million.
• The company completed a $300 million share repurchase program and authorized a new $150 million program.
• Adtalem raised its fiscal year 2025 revenue guidance to $1,760 million to $1,775 million.
• Adjusted earnings per share guidance for fiscal year 2025 was raised to $6.40 to $6.60.

Sentiment

Score: 9

Explanation: The document presents a highly positive outlook with strong financial results, increased guidance, and strategic initiatives driving growth. The management's comments are optimistic, and the company's focus on addressing healthcare workforce needs is commendable.

Positives

• Adtalem's total enrollment is up 9.8% year-over-year, indicating strong demand for its educational programs.
• Revenue increased by 12.9% year-over-year, demonstrating the company's ability to monetize its educational offerings.
• Chamberlain and Walden Universities have shown consistent enrollment growth, indicating successful program offerings.
• The company's adjusted EBITDA increased by 19.3% year-over-year, reflecting improved operational efficiency.
• The completion of a $300 million share repurchase program and authorization of a new $150 million program demonstrate a commitment to returning value to shareholders.
• Adtalem's net leverage is low at 0.8x, indicating a strong financial position.
• The company raised its fiscal year 2025 guidance, reflecting confidence in its future performance.
• American University of the Caribbean School of Medicine (AUC) and Ross University School of Medicine (RUSM) achieved a combined 95% first-time residency attainment rate for 2024-2025 graduates.

Negatives

• The Medical & Veterinary segment's operating income decreased by 21.8%, indicating potential challenges in this area.
• The Medical & Veterinary segment's adjusted EBITDA decreased by 15.3%.

Risks

• The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• These risks and uncertainties include the risk factors described in Item 1A. Risk Factors of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC.
• The U.S. is projected to face a shortage of 187,000 physicians in 2037, exacerbating healthcare gaps, particularly in existing shortage areas.

Future Outlook

Adtalem raised its fiscal year 2025 revenue guidance to $1,760 million to $1,775 million, representing approximately 11% to 12% growth year-over-year. Adjusted earnings per share are expected to be in the range of $6.40 to $6.60, approximately 28% to 32% growth year-over-year.

Management Comments

• Our focus on delivering flexible, personalized, tech enabled and career relevant programs for todays modern student has driven seven consecutive quarters of enrollment growth, said Steve Beard, chairman and chief executive officer, Adtalem Global Education.
• Rooted in operational excellence, our Growth with Purpose strategy continues to fuel sustainable returns.
• As a trusted pathway for aspiring healthcare professionals, were investing in innovative programs to meet rising demand, ensuring a skilled workforce that meets the needs of communities across the U.S.

Industry Context

Adtalem's focus on healthcare education aligns with the growing demand for healthcare professionals in the U.S., as highlighted by the projected shortage of physicians. The company's efforts to place graduates in underserved areas address critical healthcare gaps.

Comparison to Industry Standards

• Adtalem's growth in enrollment and revenue outpaces some of its competitors in the for-profit education sector, such as Apollo Education Group (which was taken private) and Career Education Corporation (now Perdoceo Education Corporation).
• The 95% first-time residency attainment rate for AUC and RUSM graduates is a strong indicator of the quality of their medical programs, comparing favorably to the national average for US medical schools.
• Adtalem's net leverage of 0.8x is conservative compared to some other education companies, providing financial flexibility for future investments and acquisitions.

Stakeholder Impact

• Shareholders will benefit from the increased earnings and share repurchase program.
• Students will benefit from the company's focus on delivering high-quality, career-relevant programs.
• Communities will benefit from the company's efforts to address healthcare workforce shortages.
• Employees will benefit from the company's growth and success.

Next Steps

• Adtalem will continue to execute its Growth with Purpose strategy.
• The company will focus on delivering flexible, personalized, tech-enabled, and career-relevant programs.
• Adtalem will invest in innovative programs to meet rising demand for healthcare professionals.
• The company will continue to return value to shareholders through share repurchases.

Key Dates

Keywords

Adtalem Global Education, enrollment, revenue, earnings, education, healthcare, university, EBITDA, guidance, share repurchase